心房颤动侦测专利技术
迈克大夫的 AFIB 心房颤动侦测专利技术可以在血压测量过程中侦测心房颤动，当屏幕显示心房颤动图标，提醒您尽早寻求专业意见。
心房顫動(AFIB)是什么？心房颤动是最致命的一种心律不齐，中风风险高出五倍迈克大夫的 AFIB 心房颤动侦测专利技术能有效筛检出最危 险致命的心律不整 - 心房颤动，排除其他因生理与人为因素 造成的心律不整。经由迈克大夫的专利技术可以在血压测量 过程中自动侦测心房颤动，使用者在 MAM 三次平均模式下 进行测量，如发现心房颤动，屏幕会显示图标提醒您尽早寻 求专业意见，帮助您了解自身健康状况。 |
.png) |
准确专注筛检心房颤动
专业证实迈克大夫的心房颤动侦测具有高度敏感性(98%)与高度特异性(92%)
学术研究累计超过 10000 名样本，
并发表于国际知名期刊。
经专业研究实证，在居家量测血压时，
能同时侦测心房颤动，可作为 AF 初筛的可靠工具。
获英国国家健康与照顾卓越研究院 NICE 官方正式推荐 :
- 专业人士推荐 ：No.1 的心房颤动侦测技术！
- Microlife 迈克大夫的心房颤动侦测技术，已通过专业实验证明了准确度，有助于筛检出新的 AFIB 个案。
- 建议使用于可能罹患高血压的高危险群＆高血压族群的血压管理。
国际专业实证列表
| Patients (n) | Setting | Average age (y) |
AF n (%) |
Non-AF n (%) |
Sinus (n) | Sensitivity (%) |
Specificity (%) |
|
|---|---|---|---|---|---|---|---|---|
| Wiesel 2004 | 450 | Hospital | 69 | 53(12) | 1 | 396 | 100 | 92 |
| Stergiou 2009 | 73 | Hospital | 71 | 27(37) | 23 | 23 | 100 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
| Wiesel 2004 | 405 | Hospital | 73 | 93(23) | 64 | 248 | 97 | 89 |
2013 Oxford Trail 牛津专业试验
著名的英国牛津大学在2013年，针对1,000名家医科患者进行了一项随机专业试验 ，研究结果表明:
Microlife 迈克大夫的 AFIB 对于心房颤动的初步筛检来说是最好的选择，量血压同时量测，操作简单不需专业解释，准确度可媲美诊间使用的单导 ECG，所以在基础健康管理与居家使用上，Microlife 迈克大夫AFIB 比 ECG 更适合做为房颤的筛检工具。
这些资料建议使用心房颤动技术进行居家血压量测，有优异的量测准确度，因此于初期量测时可用来作为可靠的筛检试验。
– Dr. George S. Stergiou
国际专业实证列表
Nichols M TN, Luengo-Fernandez R, Leal J, Gray A, Scarborough P, Rayner M European Cardiovascular Disease Statistics 2012. European Heart Network, Brussels, European Society of Cardiology, Sophia Antipolis 2012.
Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH et al.: Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 2015; 128:509-518 e502.
Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S: Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6:213-220.
Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA et al.: Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014; 370:2478-2486.
Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J et al.: Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014; 370:2467-2477.
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al.: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Europace 2012; 14:1385-1413.
Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131:492-501.
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al.: Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383:955-962.
Verberk WJ, Omboni S, Kollias A, Stergiou GS: Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations. Int J Cardiol 2016; 203:465-473.
Wiesel J, Fitzig L, Herschman Y, Messineo FC: Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.
Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M: Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009; 23:654-658.
Wiesel J, Fitzig L, Herschman Y, Messineo FC: Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009; 22:848-852.
Wiesel J, Abraham S, Messineo FC: Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol 2013; 111:1598-1601.
Kearley K, Selwood M, Van den Bruel A, Thompson M, Mant D, Hobbs FR et al.: Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open 2014; 4:e004565.
Wiesel J, Arbesfeld B, Schechter D: Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol 2014; 114:1046-1048.
Gandolfo C, Balestrino M, Bruno C, Finocchi C, Reale N: Validation of a simple method for atrial fibrillation screening in patients with stroke. Neurol Sci 2015; 36:1675-1678.
Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting. Circulation 2017; 135:110-112.
Chan PH, Wong CK, Pun L, Wong YF, Wong MM, Chu DW et al.: Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting. BMJ Open 2017; 7:e013685.
Alpert BS, Quinn D, Gallick D: Oscillometric blood pressure: a review for clinicians. J Am Soc Hypertens 2014; 8:930-938.
NICE: WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension http://guidance.nice.org.uk/MTG13. 2013; Assessed 18 Aug. 2015.
